Uses for compounds which reduce c-jun gene expression

Details Uses for compounds which reduce c-jun gene expression Uses for compounds which reduce c-jun gene expression

1998-06-05

2000-02-15

Leary, Louise N.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving viable micro-organism

C12Q 102

Patent

active

060251514

ABSTRACT:
In accordance with the present invention, it has been discovered that monocyte conditioned medium (MCM) obtained from patients with liver disease stimulates the proliferation of fibroblasts. Platelet derived growth factor (PDGF) has also been found to stimulate fibroproliferation of fibroblasts, and to be at least partially responsible for the fibroproliferative effect of the MCM. Further in accordance with the present invention, the effect of MCM and PDGF on the expression of c-fos and c-jun has been investigated, because c-fos and c-jun form AP-1 complexes which can stimulate genes involved in proliferation. It has recently been reported that pentoxifylline inhibits platelet derived growth factor-stimulated proliferation. Studies were conducted to determine whether pentoxifylline altered the expression of c-fos and c-jun. While PDGF was found to induce the expression of both c-fos and c-jun, pentoxifylline was found to effectively reduce the effect of PDGF-induced c-jun gene expression, without altering c-fos gene expression. These results suggest that pentoxifylline inhibits PDGF-stimulated proliferation by decreasing c-jun expression. These results further suggest a variety of diseases and/or conditions which may also be successfully treated with compounds, such as pentoxifylline, which reduce the transcription of c-jun gene.

REFERENCES:
patent: 4160452 (1979-07-01), Theeuwes
patent: 4256108 (1981-03-01), Theeuwes
patent: 4265874 (1981-05-01), Bonsen et al.
Bamberger, et al., "Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells" Proc. Natl. Acad. Sci. USA 93:6169-6174 (1996).
Bessler, et al., "Effect of Pentoxifylline on the Phagocytic Activity, cAMP Levels, and Superoxide Anion Production by Monocytes and Polymorphonuclear Cells" J. Leukocyte Biol. 40:747-754 (1986).
Bogoyevitch,et al., "Cellular Stresses Differentially Activate c-Jun N-terminal Protein Kinases and Extracellular Signal-regulated Protein Kinases in Cultured Ventricular Myocytes" J. Biol. Chem. 270(50):29710-17 (1995).
Buchdunger, et al., "Inhibition of the Abl Protein-Tyrosine Kinase in Vitro and in Vivo by a 2-Phenylaminopyrimidine Derivative" Cancer Res. 56:100-4 (1996).
Burgering, et al., "cAMP antagonizes p21.sup.ras -directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor" The EMBO Journal 12(11):4211-4220 (1993).
Cimminiello et al., "Platelet-Derived Growth Factor (PDGF) in Patients with Different Degress of Chronic Arterial Obstructive Disease" Angiology 45(4):289-293 (1994).
Coso, et al., "Transforming G Protein-coupled Receptors Potently Activate JNK (SAPK)" J. Biol. Chem. 270(10):5620-5624 (1995).
Crespo, et al., "Signaling through Transforming G Protein-coupled Receptors in NIH 3T3 Cells Involves c-Raf Activation" J. Biol. Chem. 269(33):21103-21109 (1994).
Davis, "The Mitogen-activated Protein Kinase Signal Transduction Pathway" R.J. J. Biol. Chem. 268(20):14553-14556 (1993).
Dohlman, et al. "Generation of a unique fibroblast-activating factor by human monocytes" Immunol. 52:577-584 (1984).
Gesualdo, et al., "Platelet-Derived Growth Factor Expression in Mesangial Proliferative Glomerulonephritis" Lab Invest. 65(2):160-167 (1991).
Herschman, H. R., "Primary Response Genes Induced by Growth Factors and Tumor Promoters" Ann. Rev. of Biochem. 60:281-319 (1991).
Hunter and Karin, "The Regulation of Transcription by Phosphorylation" Cell 70:375-387 (1992).
Imai, et al., "Effect of growth factors on hyaluronan and proteoglycan synthesis by retroocular tissue fibroblasts of Graves' ophthalmopathy in culture" Acta Endocrinologica 126:541-552 (1992).
Kuratsu, et al, "Antiproliferative effect of trapidil, a platele-derived growth factor antagonist, on a glioma cell line in virto" J. Neurosurg. 73:436-440 (1990).
Lo, et al., "Reactive Oxygen Species Mediate Cytokine Activation of c-Jun NH.sub.2 -terminal Kinases*" J. Biol. Chem. 271(26):15703-15707 (1996).
Leon and Rojkind, "A Simple Micromethod for Collagen and Total Protein Determination in Formalin-fixed Paraffin-embedded Sections.sup.1,2 " J. Histochem. and Cytochem. 33(8):737-743 (1985).
Luke and Rocci, "Determination of pentoxifylline and a major metabolite, 3,7-demethyl-1-(5'-hydroxyhexy)xanthine, by high-performance liquid chromatography" J. Chromatogr. 374(1):191-195 (1986).
Marra, et al., "Involvement of phosphatidylinositol 3-kinase in the activation of extracellular signal-regulated kinase by PDGF in hepatic stellate cells" FEBS Lett. 376:141-145 (1995).
McCormick, F., "How receptors turn Ras on" Nature 363:15-16 (1993).
Meskini et al., "Phosphodiesterase Inhibitory Profile of Some Related Xanthine Derivatives Pharmacologically Active on the Peripheral Microcirculation" Biochem. Pharmacol. 47(5):781-788 (1994).
Nakamura, et al., "Renal Platelet-Derived Growth Factor Gene Expression in NZB/W F1 Mice with Lupus and ddY Mice with IgA Nephropathy" Clin. Immunol. Immunopathol. 63(2):173-181 (1992).
Palech, S.L., "Networking with protein kinases" Curr. Biol.3(8):513-515 (1993).
Pesonen, E., "Infection and intimal thickening: evidence from coronary arteries in children" Eur. Heart J. 15(Suppl X):57-61 (1994).
Peterson, "Interleukin-1, platelet derived growth factor, free radicals and monocyte aryl hydrocarbon hydroxylase activity in liver disease. Role of cell communication" Biochem. Pharmacol. 43(5):1163-1166 (1992).
Peterson, T.C., "Pentoxifylline Prevents Fibrosis in an Animal Model and Inhibits Platelet-derived Growth Factor-driven Proliferation of Fibroblasts" Hepatol. 17(3):486-493 (1993).
Peterson, T.C. "Inhibition of Fibroproliferation by Pentoxifylline Activity of Metabolite-1 and Lack of Role of Adenosine Receptors" Biochem. Pharmacol. 52:597-602 (1996).
Peterson and Isbrucker, "Fibroproliferation in Liver Disease: Role of Monocyte Factors" Hepatol. 15(2):191-197 (1992).
Peterson and Neumeister, "Effect of pentoxifylline in rat and swine models of hepatic fibrosis: role of fibroproliferation in its mechanism" Immunopharmacol. 31:183-193 (1996).
Peterson and Tanton, "Effect of Pentoxifylline in Collagenous Colitis" Can. J. Gastroenterol. 10:S76 (1996).
Peterson et al., "In vitro effect of platelet-derived growth factor on fibroproliferation and effect of cytokine antagonists" Immunopharmacol. 28:259-270 (1994).
Pietrogrande, et al., "A Role for Platelet-Derived Growth Factor in Drug-Induced Chronic Ergotism? A Case Report" Angiology 46(7):633-636 (1995).
Rosenwald, et al., "Transient inhibition of protein synthesis induces expression of protooncogenes and stimulates resting cells to enter the cell cycle" Cell Prolif. 28:631-644 (1995).
Schafer, et al., "PACAP Stimulates Transcription of c-Fos and c-Jun and Activates the P-1 Transcription Factor in Rat Pancreatic Carcinoma Cells" Biochem. Biophys. Res. Commun. 221:111-116 (1996).
Schlesinger, J., "How receptor tyrosine kinases activate Rats" Trends Biochem. Sci., 18:273-275 (1993).
Shaw, et al., "Pathogenesis of Pulmonary Fibrosis in Interstitial Lung Disease" Am. Rev. Respir. Dis. 143:167-173 (1991).
Terano, et al., "Eicosapentaenoic Acid Suppressed the Proliferation of Vascular Smooth Muscle cells Through Modulation of Various Steps of Growth Signals" Lipids 31:S301-S304 (1996).
Uebelhoer, et al., "Modulation of Fibroblast Activity in Histiocytosis X by Platelet-Derived Growth Factor" Chest 107:701-705 (1995).
Wu et al., "Inhibition of the EGF-Activated MAP Kinase Signaling Pathway by Adenosine 3',5'-Monophosphate" Science 262:1065-1069 (1993).
Xie and Hershcan, "v-src Induces Prostaglandin Synthase 2 Gene Expression by Activation of the c-Jun. N-terminal Kinase and the c-Jun. Transcription Factor*" J. Biol. Chem. 270:27622-27628 (1995).
Yoshida, et al., "Involvement of Interleukin-8, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Tumor Necrosis Factor Alpha-Dependent Angiogenesis" Molecular and Cellular Biology 17(7):4015-4023 (1997).
Zar, J.H. in Biostatistical methods. Prentice-Hall (Englewood Cliffs, N.J., 1974).

Affiliated with

Also associated with

Rating

Uses for compounds which reduce c-jun gene expression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Uses for compounds which reduce c-jun gene expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uses for compounds which reduce c-jun gene expression will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1904816